Rockeby signs HK distributor

By Melissa Trudinger
Monday, 12 January, 2004

Recently floated diagnostics company Rockeby Biomed (ASX:RBY) has signed up Asia-Pacific healthcare and pharmaceutical distributor JDH Healthcare as its exclusive distributor for its Candia5 Rapid Test kit in Hong Kong and Macau.

The unique test for vaginal candidiasis (thrush) -- a disease that affects 75 per cent of women at least once in their lifetime -- will be initially marketed there as a point of care test available from general practitioners, gynaecologists and obstetricians.

It has already been launched in several other Asia-Pacific markets including Australia, New Zealand, Singapore and Malaysia.

The Singapore- and Australia-based company listed on the ASX on December 23rd at AUD$0.20 and at the time of writing was trading at $0.245.

Related News

Perinatal HIV transmission may lead to cognitive deficits

Perinatal transmission of HIV to newborns is associated with serious cognitive deficits as...

Gene editing could make quolls resistant to cane toad toxin

Scientists from Colossal Biosciences and The University of Melbourne have introduced genetic...

New anti-clotting agent has its own 'off switch'

The anticoagulant's anti-clotting action can be rapidly stopped on demand, which could enable...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd